scispace - formally typeset
D

Donal J. Brennan

Researcher at Mater Misericordiae University Hospital

Publications -  150
Citations -  7861

Donal J. Brennan is an academic researcher from Mater Misericordiae University Hospital. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 42, co-authored 129 publications receiving 6598 citations. Previous affiliations of Donal J. Brennan include University College Dublin & Mater Health Services.

Papers
More filters
Journal ArticleDOI

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer

TL;DR: In this paper, a case-controlled study at a tertiary teaching hospital in Dublin was conducted to assess the impact of cytoreductive surgery with or without the addition of HIPEC on renal function.
Journal ArticleDOI

The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology

TL;DR: The BDII/Han rat model is a suitable model of diet-induced obesity in endometrioid cancer and can be used to identify clinically relevant biomarkers in human EC.
Journal ArticleDOI

Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study.

TL;DR: In this paper, a multicentre prospective observational study was conducted between March 24th and August 31st 2020, where two independent cohorts were established, a symptomatic SARS-CoV-2 cohort and a cohort of asymptomatic pregnant women attending two of the largest maternity hospitals in Europe.
Posted ContentDOI

Challenges of False Positive and Negative Results in Cervical Cancer Screening

TL;DR: As HPV vaccination rates increase, HPV based screening approaches result in fewer unnecessary colposcopies than LBC approaches, and the clinical relevance of cervical cancer screening is crucially dependent upon the prevalence of cervical dysplasia and/or HPV infection or vaccination in a given population.
Proceedings ArticleDOI

Abstract LB-444: SATB2 is a novel prognostic factor in colorectal cancer

TL;DR: It is postulated that SATB2 acts as a master regulator of the inflammatory response in the gut and loss of expression is significantly associated with the progression of colorectal cancer.